Show simple item record

Topical immunotherapy with diphenylcyclopropenone-induced vitiligo

dc.contributor.authorEngin, Burhan
dc.contributor.authorSerdaroglu, Server
dc.contributor.authorSongur, Abdullah
dc.contributor.authorTuzun, Yalcin
dc.contributor.authorKutlubay, Zekayi
dc.date.accessioned2021-03-05T18:57:38Z
dc.date.available2021-03-05T18:57:38Z
dc.date.issued2016
dc.identifier.citationKutlubay Z., Engin B., Songur A., Serdaroglu S., Tuzun Y., "Topical immunotherapy with diphenylcyclopropenone-induced vitiligo", JOURNAL OF COSMETIC AND LASER THERAPY, cilt.18, ss.245-246, 2016
dc.identifier.issn1476-4172
dc.identifier.otherav_cced0383-1463-4b17-8925-92e89ba00add
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/135655
dc.identifier.urihttps://doi.org/10.3109/14764172.2016.1157357
dc.description.abstractTopical immunotherapy made by diphenylcyclopropenone (DPCP) is an alternative treatment that can be used safely and efficaciously in recalcitrant alopecia areata patients. DPCP-induced vitiligo is a rare, but documented, unwanted side effect. The real mechanism of DPCP-induced vitiligo is not well known.
dc.language.isoeng
dc.subjectCerrahi Tıp Bilimleri
dc.subjectTıp
dc.subjectDermatoloji
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectCERRAHİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectDERMATOLOJİ
dc.titleTopical immunotherapy with diphenylcyclopropenone-induced vitiligo
dc.typeMakale
dc.relation.journalJOURNAL OF COSMETIC AND LASER THERAPY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume18
dc.identifier.issue4
dc.identifier.startpage245
dc.identifier.endpage246
dc.contributor.firstauthorID227758


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record